127 related articles for article (PubMed ID: 2323155)
1. Quantification of the EEG effect of midazolam by aperiodic analysis in volunteers. Pharmacokinetic/pharmacodynamic modelling.
Breimer LT; Hennis PJ; Burm AG; Danhof M; Bovill JG; Spierdijk J; Vletter AA
Clin Pharmacokinet; 1990 Mar; 18(3):245-53. PubMed ID: 2323155
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic-pharmacodynamic modelling of the interaction between flumazenil and midazolam in volunteers by aperiodic EEG analysis.
Breimer LT; Burm AG; Danhof M; Hennis PJ; Vletter AA; de Voogt JW; Spierdijk J; Bovill JG
Clin Pharmacokinet; 1991 Jun; 20(6):497-508. PubMed ID: 2044333
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic-pharmacodynamic modeling of electroencephalographic effects of midazolam in eight Chinese men.
Lu JF; Chen G; Xiang BR; An DK
Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):399-403. PubMed ID: 7717060
[TBL] [Abstract][Full Text] [Related]
4. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.
Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI
J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration.
Mandema JW; Tukker E; Danhof M
Br J Pharmacol; 1991 Mar; 102(3):663-8. PubMed ID: 1364836
[TBL] [Abstract][Full Text] [Related]
6. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
[TBL] [Abstract][Full Text] [Related]
7. In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy.
Mandema JW; Kuck MT; Danhof M
J Pharmacol Exp Ther; 1992 Apr; 261(1):56-61. PubMed ID: 1560385
[TBL] [Abstract][Full Text] [Related]
8. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil.
Mandema JW; Tukker E; Danhof M
J Pharmacol Exp Ther; 1992 Jan; 260(1):36-44. PubMed ID: 1309878
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic modeling of midazolam effects on the human central nervous system.
Koopmans R; Dingemanse J; Danhof M; Horsten GP; van Boxtel CJ
Clin Pharmacol Ther; 1988 Jul; 44(1):14-22. PubMed ID: 3391000
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam.
Fiset P; Lemmens HL; Egan TD; Shafer SL; Stanski DR
Clin Pharmacol Ther; 1995 Nov; 58(5):567-82. PubMed ID: 7586951
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo.
Greenblatt DJ; Ehrenberg BL; Gunderman J; Locniskar A; Scavone JM; Harmatz JS; Shader RI
Clin Pharmacol Ther; 1989 Apr; 45(4):356-65. PubMed ID: 2702793
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic-EEG effect relationship of midazolam in aging BN/BiRij rats.
Hovinga S; Stijnen AM; Langemeijer MW; Mandema JW; van Bezooijen CF; Danhof M
Br J Pharmacol; 1992 Sep; 107(1):171-7. PubMed ID: 1422570
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers.
Mandema JW; Tuk B; van Steveninck AL; Breimer DD; Cohen AF; Danhof M
Clin Pharmacol Ther; 1992 Jun; 51(6):715-28. PubMed ID: 1611810
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of heptabarbital using aperiodic EEG analysis.
Mandema JW; Danhof M
J Pharmacokinet Biopharm; 1990 Oct; 18(5):459-81. PubMed ID: 1979991
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic interaction between midazolam and a low dose of ethanol in vivo.
Hoyo-Vadillo C; Mandema JW; Danhof M
Life Sci; 1995; 57(4):325-33. PubMed ID: 7603305
[TBL] [Abstract][Full Text] [Related]
16. Semilinear canonical correlation applied to the measurement of the electroencephalographic effects of midazolam and flumazenil reversal.
Schnider TW; Minto CF; Fiset P; Gregg KM; Shafer SL
Anesthesiology; 1996 Mar; 84(3):510-9. PubMed ID: 8659777
[TBL] [Abstract][Full Text] [Related]
17. Mechanism-based pharmacodynamic modeling of the interaction of midazolam, bretazenil, and zolpidem with ethanol.
Tuk B; van Gool T; Danhof M
J Pharmacokinet Pharmacodyn; 2002 Jun; 29(3):235-50. PubMed ID: 12449497
[TBL] [Abstract][Full Text] [Related]
18. A pilot pharmacokinetic-pharmacodynamic study of benzodiazepine antagonism by flumazenil and aminophylline.
Bonfiglio MF; Fisher-Katz LE; Saltis LM; Traeger SM; Martin BR; Nackes NA; Perkins TA
Pharmacotherapy; 1996; 16(6):1166-72. PubMed ID: 8947991
[TBL] [Abstract][Full Text] [Related]
19. Physostigmine reversal of midazolam-induced electroencephalographic changes in healthy subjects.
Ebert U; Oertel R; Kirch W
Clin Pharmacol Ther; 2000 May; 67(5):538-48. PubMed ID: 10824633
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and EEG effects of flumazenil in volunteers.
Breimer LT; Hennis PJ; Burm AG; Danhof M; Bovill JG; Spierdijk J; Vletter AA
Clin Pharmacokinet; 1991 Jun; 20(6):491-6. PubMed ID: 2044332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
